High frequency of teratogen prescriptions to women of reproductive age with rheumatic disease.
Publication
, Journal Article
Clowse, MEB; Li, J; Snyderman, AG; Schmajuk, G
Published in: Arthritis Rheumatol
August 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Arthritis Rheumatol
DOI
EISSN
2326-5205
Publication Date
August 2023
Volume
75
Issue
8
Start / End Page
1495
Location
United States
Related Subject Headings
- Teratogens
- Rheumatic Diseases
- Prescriptions
- Humans
- Female
- Contraception
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Clowse, M. E. B., Li, J., Snyderman, A. G., & Schmajuk, G. (2023). High frequency of teratogen prescriptions to women of reproductive age with rheumatic disease. Arthritis Rheumatol, 75(8), 1495. https://doi.org/10.1002/art.42461
Clowse, Megan E. B., Jing Li, Amanda G. Snyderman, and Gabriela Schmajuk. “High frequency of teratogen prescriptions to women of reproductive age with rheumatic disease.” Arthritis Rheumatol 75, no. 8 (August 2023): 1495. https://doi.org/10.1002/art.42461.
Clowse MEB, Li J, Snyderman AG, Schmajuk G. High frequency of teratogen prescriptions to women of reproductive age with rheumatic disease. Arthritis Rheumatol. 2023 Aug;75(8):1495.
Clowse, Megan E. B., et al. “High frequency of teratogen prescriptions to women of reproductive age with rheumatic disease.” Arthritis Rheumatol, vol. 75, no. 8, Aug. 2023, p. 1495. Pubmed, doi:10.1002/art.42461.
Clowse MEB, Li J, Snyderman AG, Schmajuk G. High frequency of teratogen prescriptions to women of reproductive age with rheumatic disease. Arthritis Rheumatol. 2023 Aug;75(8):1495.
Published In
Arthritis Rheumatol
DOI
EISSN
2326-5205
Publication Date
August 2023
Volume
75
Issue
8
Start / End Page
1495
Location
United States
Related Subject Headings
- Teratogens
- Rheumatic Diseases
- Prescriptions
- Humans
- Female
- Contraception
- 3204 Immunology
- 3202 Clinical sciences